What is the reference range for Follicle-Stimulating Hormone (FSH) in children by age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FSH Reference Ranges in Children by Age

Prepubertal Children (Ages 2-12 years)

FSH levels in prepubertal children remain consistently low, with mean serum concentrations below 3.0 IU/L until approximately age 10 years in girls and age 12 years in boys. 1, 2

Infancy (0-6 months)

  • FSH levels are transiently elevated during the first 6 months of life 1, 3
  • Female infants demonstrate higher FSH concentrations compared to male infants during this period 1
  • After 6 months, FSH levels decline and remain low throughout childhood 3

Early Childhood (6 months to 2 years)

  • FSH concentrations drop to low but measurable levels following the initial postnatal surge 1
  • These levels remain relatively stable throughout the prepubertal years 3

Late Childhood (2-12 years)

  • Mean prepubertal FSH levels stay below 3.0 IU/L in both sexes 2
  • Urinary FSH excretion in prepubertal children (ages 2-6 years) averages 2.2 U per liter 4
  • FSH remains detectable but at very low concentrations using sensitive immunoassays 1, 5

Pubertal Children (Ages 10-18 years)

During puberty, FSH levels increase approximately 3-fold from prepubertal baseline, with mean concentrations rising to about 5 IU/L in boys and 10 IU/L in girls. 2

Early Puberty (Tanner Stages 2-3)

  • FSH begins to rise earlier than LH in the pubertal transition 1
  • Peak GnRH-stimulated FSH is highest in prepubertal females compared to males 1
  • The increase in FSH is more gradual compared to the dramatic rise in LH 5

Mid to Late Puberty (Tanner Stages 4-5)

  • FSH values reach adult levels, with urinary concentrations approximately 5 IU/L in boys and 10 IU/L in girls 2
  • The FSH:LH ratio decreases from 5:1 in childhood to approximately 1:1 in adulthood 4

Clinical Evaluation Thresholds

Failure to initiate puberty by age 13 years in girls (no Tanner stage 2 breast development) requires laboratory evaluation of FSH and estradiol levels. 6, 7

When to Measure FSH

  • Prepubertal females age ≥11 years with delayed puberty should undergo FSH evaluation 6
  • Girls with no signs of puberty by age 13 years require FSH measurement 6, 7
  • Primary amenorrhea by age 16 years necessitates FSH testing 6
  • Failure of pubertal progression for ≥12 months warrants FSH assessment 8, 7

Interpretation Considerations

  • FSH measurement should use sensitive immunochemiluminometric assays (ICMA) or time-resolved immunofluorometric assays for accurate detection of low prepubertal levels 1, 5
  • Normal ranges vary significantly by age, sex, and pubertal stage, requiring age-appropriate reference values 6, 3
  • Two elevated FSH levels in the menopausal range (based on laboratory-specific thresholds) combined with amenorrhea ≥4 months defines premature ovarian insufficiency in females under age 40 years 8, 6

Important Caveats

  • Older radioimmunoassay methods lack sensitivity for accurate measurement of low prepubertal FSH levels; modern ICMA or immunofluorometric assays are essential 1
  • FSH levels should be interpreted in conjunction with LH and estradiol/testosterone to fully assess gonadotropin axis function 6, 1
  • In menstruating females, FSH should ideally be measured during the early follicular phase (days 2-5) for accurate interpretation 8, 6
  • Random FSH measurement is acceptable in amenorrheic patients 6

References

Research

Age-related course of urinary gonadotropins in children.

The Journal of clinical endocrinology and metabolism, 1995

Guideline

Hormone Testing in Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Menarche and Cardiovascular Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.